STRL (STRL)

$13.9B
Market Cap
48.3
P/E Ratio
1.50
Beta
Dividend Yield
Piotroski 5/9Altman Z 7.4 SafeBeneish M -2.04 Flag (> −2.22)ROIC−WACC +7.2%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 7.4. Beneish M-Score of -2.04 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company demonstrates robust fundamental economics, evidenced by a ROIC of 21.0% that significantly outpaces its WACC of 13.8%, generating a +7.2% spread indicative of efficient capital deployment. This strong return on invested capital is underpinned by a DuPont-decomposed ROE of 26.2%, driven primarily by high leverage (Equity Multiplier of 2.38x) rather than exceptional margin expansion or asset turnover efficiency, with net margins at 11.7% and turnover at 0.95x. Creditworthiness appears stable given an Altman Z-Score of 7.4, while the Beneish M-Score of -2.04 suggests low earnings manipulation risk; however, a Piotroski F-Score of 5/9 indicates moderate financial strength with room for improvement in balance sheet quality or profitability trends compared to top-tier peers.

Valuation metrics present a notable divergence between current market pricing and intrinsic value models. The stock trades at a forward P/E of 48.3x, which implies aggressive growth expectations that may exceed historical norms or sector averages absent specific comparative data points provided herein. Conversely, the DCF model assigns a fair value of $256, suggesting the current market price could be elevated relative to discounted cash flow projections if it commands a premium above this level. This valuation gap reflects potential optimism regarding future revenue growth, currently running at 17.7% year-over-year, though such high multiples leave little margin for error in execution or macroeconomic shifts.

Significant insider activity warrants attention as a counterweight to the positive fundamental metrics; over the last 90 days, insiders have executed $69,233,395 in net selling. This substantial outflow of capital from those with superior information access may signal caution regarding near-term valuation sustainability or future growth trajectories, despite the company's strong ROIC and low manipulation scores. The combination of high leverage-driven returns, elevated valuations relative to DCF estimates, and heavy insider divestment creates a complex risk-reward profile where fundamental quality does not yet fully align with shareholder sentiment or pricing models.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.8%13.8%15.8%
2%$294$240$201
3%$320$256$212
4%$353$276$225

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.8%, terminal growth 3%. Fair value $256 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
7.4
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.04
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

23.0%
Gross Margin
11.7%
Net Margin
21.0%
ROIC
13.8%
WACC
ROIC − WACC Spread: +7.2%— Positive value creation spread.
+17.7%
Revenue Growth (YoY)
+12.7%
Earnings Growth (YoY)
362.7M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

11.7%
Net Profit Margin
NI ÷ Revenue
×
0.95x
Asset Turnover
Revenue ÷ Assets
×
2.38x
Equity Multiplier
Assets ÷ Equity
=
26.2%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.38x
Debt / Equity
1.01x
Current Ratio
21.6x
Interest Coverage
-0.2x
Net Debt / EBITDA
2.63%
FCF Yield
505.4M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$69M
Net Selling
0
Buy Transactions
7
Sale Transactions
2026-03-25CUTILLO JOSEPH ASold 2/8 qtrsSale$23M
2026-03-12WILSON DWAYNE ANDREESold 1/8 qtrsSale$511,496
2026-03-10CUTILLO JOSEPH ASold 2/8 qtrsSale$41M
2026-03-09DILL JULIE ANNSold 1/8 qtrsSale$2M
2026-03-05WILSON DWAYNE ANDREESold 1/8 qtrsSale$494,832

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.45
Act: $1.63
+12.6%
Q3
✓ Beat
Est: $2.25
Act: $2.51
+11.4%
Q2
✓ Beat
Est: $2.84
Act: $3.48
+22.6%
Q1
✓ Beat
Est: $2.63
Act: $3.08
+17.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

29.2
Forward P/E
PEG Ratio
12.54
Price/Book
501367
Avg Volume
$477.03
52W High
$96.34
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.2B
Tracked Passive Exposure
8
ETFs Holding STRL
0.29%
Avg Weight in ETFs
$395B
Total ETF AUM

When investors buy or sell ETFs like MDYG or IWO, the fund manager is mechanically forced to buy or sell STRL shares regardless of STRL's individual fundamentals. We estimate $1.2B of passive capital is structurally linked to STRL through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in STRL to visualize passive redemption contagion across ETFs and collateral stocks.

STRL Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
STRLEpicenterVBETFVXFETFVBKETFFLEXMed RiskBELow RiskFNLow RiskFTILow RiskTWLOLow Risk
STRL Price Drop (%)0

If STRL (STRL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with STRL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 12 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

STRL Ownership Dynamics

Ticker
STRL

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

STRL Capital Efficiency

How efficiently does STRL convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$363M
EBITDA
$505M
FCF Conversion
72%
Reinvestment Rate
28%
72% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
21.0%
ROIC − WACC Spread
7.2%

STRL converts 72% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 7.2% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-11121$844.80$102,220.8
2026-05-07678$886.22$600,857.16
2026-05-062,066$806.00$1.7M
2026-05-054$529.49$2,117.96
2026-05-04139$532.67$74,041.13
2026-05-0133$515.62$17,015.46
2026-04-27423$497.18$210,307.14
2026-04-24519$495.67$257,252.73
2026-04-21420$472.90$198,618
2026-04-20200$463.65$92,730
2026-04-15392$464.54$182,099.68
2026-04-078,103$393.71$3.2M
2026-04-0284$421.29$35,388.36
2026-03-25782$446.16$348,897.12
2026-03-20221$431.78$95,423.38
2026-03-10675$411.38$277,681.5
2026-02-272,003$433.34$867,980.02
2026-02-2318,119$435.50$7.9M
2026-02-108,094$418.61$3.4M
2026-02-09405$401.29$162,522.45
2026-02-067,583$365.07$2.8M
2026-02-0553$360.16$19,088.48
2026-02-047,166$386.78$2.8M
2026-01-3012,200$379.23$4.6M
2026-01-292,314$373.52$864,325.28
2026-01-231,966$364.25$716,115.5
2026-01-21272$349.59$95,088.48
2026-01-202,100$350.96$737,016
2026-01-12912$308.13$281,014.56
2026-01-0221$306.23$6,430.83

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare STRL to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.